A business in context

RDGL research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-07 · 0001493152-26-046354 · Items 1.01,3.02,3.03,5.03,9.01

  2. 4 · Ownership change

    Report date 2026-10-07 · 0001486807-26-000002

  3. 8-K · Current report

    Report date 2026-09-28 · 0001493152-26-045780 · Items 5.03,9.01

  4. 4 · Ownership change

    Report date 2026-09-30 · 0001486806-26-000010

  5. 4 · Ownership change

    Report date 2026-09-16 · 0002131351-26-000014

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-037380

  7. 4 · Ownership change

    Report date 2026-08-10 · 0002131351-26-000012

  8. 4 · Ownership change

    Report date 2026-08-10 · 0001486806-26-000008

  9. 4 · Ownership change

    Report date 2026-07-21 · 0002131351-26-000010

  10. 4/A · Ownership change

    Report date 2026-03-31 · 0002131351-26-000008

  11. 4 · Ownership change

    Report date 2026-07-15 · 0001486806-26-000006

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-023146

  13. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-013701

  14. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-021619

  15. 8-K/A · Current report

    Report date 2025-09-15 · 0001493152-25-014694 · Items 1.01,5.02,9.01

  16. 8-K · Current report

    Report date 2025-09-15 · 0001493152-25-014345 · Items 1.01,5.02,9.01

  17. 8-K · Current report

    Report date 2025-09-17 · 0001493152-25-014047 · Items 8.01

  18. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-023437

  19. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-009496

  20. 10-K · Annual report

    Report date 2024-12-31 · 0001641172-25-000238

  21. 8-K · Current report

    Report date 2025-02-04 · 0001493152-25-005623 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-02-06 · 0001493152-25-005588 · Items 3.02,8.01

  23. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001493152-24-045032

  24. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001493152-24-031540

  25. 8-K · Current report

    Report date 2024-06-28 · 0001493152-24-025735 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001493152-24-018525

  27. 8-K · Current report

    Report date 2023-12-19 · 0001493152-24-011040 · Items 1.01,5.02,9.01

  28. 10-K · Annual report

    Report date 2023-12-31 · 0001493152-24-010256

  29. 8-K · Current report

    Report date 2023-12-22 · 0001493152-23-046266 · Items 3.02,8.01,9.01

  30. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001493152-23-039464

  31. 8-K · Current report

    Report date 2023-10-10 · 0001493152-23-036853 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001493152-23-026796

  33. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001493152-23-015400

  34. 8-K · Current report

    Report date 2023-05-01 · 0001493152-23-015144 · Items 3.02,8.01

  35. 10-K · Annual report

    Report date 2022-12-31 · 0001493152-23-006366

  36. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001493152-22-028874

  37. 10-Q · Quarterly report

    Report date 2022-06-30 · 0001493152-22-020190

  38. 8-K · Current report

    Report date 2022-07-07 · 0001493152-22-018978 · Items 3.02,8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2022-03-31 · 0001493152-22-012660

  40. 10-K · Annual report

    Report date 2021-12-31 · 0001493152-22-006171

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 10 transaction rows10PSale: 0 transaction rows0SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-16
2026-09-16
Weeks Brad AllanP · Purchase
Acquired
Common Stock25550.00.05
2026-08-10
2026-08-10
Weeks Brad AllanP · Purchase
Acquired
Common Stock50000.00.05
2026-08-10
2026-08-10
Korenko Michael KP · Purchase
Acquired
Common Stock150000.00.05
2026-07-22
2026-07-22
Weeks Brad AllanP · Purchase
Acquired
Common Stock32000.00.05
2026-07-21
2026-07-22
Weeks Brad AllanP · Purchase
Acquired
Common Stock60000.00.05
2026-07-15
2026-07-15
Korenko Michael KP · Purchase
Acquired
Common Stock200000.00.06
2026-07-10
2026-07-15 · Amendment
Weeks Brad AllanP · Purchase
Acquired
Common Stock12000.00.08
2026-07-10
2026-07-10
Weeks Brad AllanP · Purchase
Acquired
Common Stock12000.00.08
2026-07-09
2026-07-15 · Amendment
Weeks Brad AllanP · Purchase
Acquired
Common Stock48000.00.08
2026-07-09
2026-07-10
Weeks Brad AllanP · Purchase
Acquired
Common Stock48000.00.08
2026-06-30
2026-07-15 · Amendment
Weeks Brad AllanA · Grant / award
Acquired
Common Stock147159.00.0
2026-03-31
2026-07-15 · Amendment
Weeks Brad AllanA · Grant / award
Acquired
Common Stock100111.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001449349VIVOS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • ADVANCED MEDICAL ISOTOPE Corp · former SEC name · 2008-11-12 to 2017-12-18

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$28.0K$30.1K
2023-12-31$19.5K$21.6K
2022-12-31$36.5K$42.0K
2021-12-31$14.9K$18.5K
2020-12-31$7.0K$9.1K
2019-12-31$9.5K$12.5K

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗